Differences among the drugs became more noticeable in the comparative pattern: Semaglutide showed a 42% lower risk of worsening mental illness Liraglutide showed about an 18% lower risk Exenatide and dulaglutide did not show similarly strong reductions in the summarized reports Such variation suggests outcomes may not be consistent across every drug in the GLP-1 category
FAQ Your questions, answered Weve answered some of the most common questions below to help make your experience simple, transparent, and stress-free
Phase 2 trial [1]
(Source: Healthline, May 2026) Sequential Treatment Is Increasingly Common And Works Well A separate 2026 analysis found that patients who started on GLP-1 therapy and later transitioned to bariatric surgery whether due to side effects, medication unavailability, or seeking definitive treatment had surgical outcomes and quality-of-life scores comparable to patients who went straight to surgery
Clinical trials show that patients taking semaglutide for weight management lost 14.9% of their body weight in 68 weeks compared to 2.4% weight loss in the placebo group
Ideal Storage Conditions: Temperature, Light, and Moisture Semaglutide needs to be kept under specific conditions to stay effective